Needham & Company LLC Reiterates Hold Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

Key Points

• Needham & Company LLC has restated its "hold" rating for DENTSPLY SIRONA (NASDAQ:XRAY) amid multiple price target adjustments from various brokerages.
• DENTSPLY SIRONA's stock has shown a 52-week range between $12.16 and $27.44, currently trading at $12.37, with a market cap of $2.47 billion.
• In its latest earnings report, DENTSPLY SIRONA reported earnings per share of $0.52, slightly surpassing analysts' expectations while experiencing a 4.9% decline in year-over-year revenue.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report)'s stock had its "hold" rating restated by analysts at Needham & Company LLC in a research note issued to investors on Friday,Benzinga reports.

Several other brokerages have also recently issued reports on XRAY. Stifel Nicolaus reduced their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research note on Friday, August 8th. Wall Street Zen cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Friday, August 8th. UBS Group reduced their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Finally, Barrington Research cut their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $12.37 on Friday. The stock has a 50 day moving average of $14.20 and a 200-day moving average of $14.84. DENTSPLY SIRONA has a 52 week low of $12.16 and a 52 week high of $27.44. The stock has a market cap of $2.47 billion, a P/E ratio of -2.61, a price-to-earnings-growth ratio of 0.80 and a beta of 0.96. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million for the quarter, compared to analysts' expectations of $929.67 million. During the same period last year, the business posted $0.49 earnings per share. The firm's revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, analysts expect that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in shares of DENTSPLY SIRONA by 2.8% during the first quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier's stock valued at $309,864,000 after purchasing an additional 557,329 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in shares of DENTSPLY SIRONA by 11.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier's stock valued at $208,590,000 after purchasing an additional 1,412,517 shares during the period. AQR Capital Management LLC increased its holdings in shares of DENTSPLY SIRONA by 109.8% during the second quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier's stock valued at $211,470,000 after purchasing an additional 6,970,086 shares during the period. Fuller & Thaler Asset Management Inc. increased its holdings in shares of DENTSPLY SIRONA by 4.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier's stock valued at $180,445,000 after purchasing an additional 538,531 shares during the period. Finally, Lazard Asset Management LLC increased its holdings in shares of DENTSPLY SIRONA by 8.0% during the second quarter. Lazard Asset Management LLC now owns 10,107,657 shares of the medical instruments supplier's stock valued at $160,508,000 after purchasing an additional 745,421 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.